Sodium in PDB 5a2m: Thrombin Inhibitor
Enzymatic activity of Thrombin Inhibitor
All present enzymatic activity of Thrombin Inhibitor:
3.4.21.5;
Protein crystallography data
The structure of Thrombin Inhibitor, PDB code: 5a2m
was solved by
E.Ruehmann,
A.Heine,
G.Klebe,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
35.62 /
1.40
|
Space group
|
C 1 2 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
70.114,
71.242,
72.368,
90.00,
100.13,
90.00
|
R / Rfree (%)
|
13.7 /
15.9
|
Other elements in 5a2m:
The structure of Thrombin Inhibitor also contains other interesting chemical elements:
Sodium Binding Sites:
The binding sites of Sodium atom in the Thrombin Inhibitor
(pdb code 5a2m). This binding sites where shown within
5.0 Angstroms radius around Sodium atom.
In total 2 binding sites of Sodium where determined in the
Thrombin Inhibitor, PDB code: 5a2m:
Jump to Sodium binding site number:
1;
2;
Sodium binding site 1 out
of 2 in 5a2m
Go back to
Sodium Binding Sites List in 5a2m
Sodium binding site 1 out
of 2 in the Thrombin Inhibitor
 Mono view
 Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 1 of Thrombin Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
H:Na1247
b:16.1
occ:1.00
|
O
|
H:LYS169
|
2.3
|
17.8
|
1.0
|
O
|
H:THR172
|
2.3
|
17.0
|
1.0
|
O
|
H:HOH2148
|
2.5
|
26.0
|
1.0
|
HA
|
H:ASP170
|
3.2
|
21.0
|
1.0
|
C
|
H:LYS169
|
3.4
|
17.1
|
1.0
|
H
|
H:THR172
|
3.5
|
19.3
|
1.0
|
C
|
H:THR172
|
3.6
|
16.5
|
1.0
|
HA
|
H:ARG173
|
3.7
|
20.3
|
1.0
|
CA
|
H:ASP170
|
4.0
|
17.5
|
1.0
|
N
|
H:ASP170
|
4.1
|
17.1
|
1.0
|
HG21
|
H:THR172
|
4.1
|
21.8
|
1.0
|
HB3
|
H:LYS169
|
4.2
|
23.8
|
1.0
|
N
|
H:THR172
|
4.3
|
16.1
|
1.0
|
C
|
H:ASP170
|
4.4
|
17.4
|
1.0
|
HA
|
H:LYS169
|
4.4
|
20.1
|
1.0
|
CA
|
H:ARG173
|
4.5
|
16.9
|
1.0
|
N
|
H:ARG173
|
4.5
|
16.4
|
1.0
|
CA
|
H:LYS169
|
4.5
|
16.7
|
1.0
|
CA
|
H:THR172
|
4.5
|
16.8
|
1.0
|
HG23
|
H:THR172
|
4.6
|
21.8
|
1.0
|
OD1
|
H:ASP170
|
4.6
|
19.6
|
1.0
|
O
|
H:ASP170
|
4.8
|
17.7
|
1.0
|
CG2
|
H:THR172
|
4.8
|
18.2
|
1.0
|
CB
|
H:LYS169
|
4.8
|
19.8
|
1.0
|
N
|
H:SER171
|
4.8
|
17.6
|
1.0
|
H
|
H:SER171
|
4.9
|
21.1
|
1.0
|
H
|
H:ASP170
|
4.9
|
20.5
|
1.0
|
O
|
H:ILE174
|
4.9
|
17.8
|
1.0
|
C
|
H:ARG173
|
5.0
|
18.4
|
1.0
|
|
Sodium binding site 2 out
of 2 in 5a2m
Go back to
Sodium Binding Sites List in 5a2m
Sodium binding site 2 out
of 2 in the Thrombin Inhibitor
 Mono view
 Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 2 of Thrombin Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
H:Na1248
b:19.7
occ:1.00
|
O
|
H:HOH2172
|
2.3
|
19.9
|
1.0
|
O
|
H:HOH2189
|
2.3
|
21.1
|
1.0
|
O
|
H:ARG221A
|
2.4
|
22.5
|
1.0
|
O
|
H:LYS224
|
2.4
|
18.1
|
1.0
|
O
|
H:HOH2162
|
2.5
|
17.3
|
1.0
|
O
|
H:HOH2164
|
2.7
|
25.5
|
1.0
|
H
|
H:LYS224
|
3.2
|
24.6
|
1.0
|
C
|
H:ARG221A
|
3.4
|
22.3
|
1.0
|
C
|
H:LYS224
|
3.4
|
18.0
|
1.0
|
HA
|
H:ASP221
|
3.7
|
25.3
|
1.0
|
HA
|
H:ASP222
|
3.8
|
30.3
|
1.0
|
HB2
|
H:LYS224
|
3.8
|
24.4
|
1.0
|
N
|
H:LYS224
|
3.8
|
20.5
|
1.0
|
H
|
H:GLY223
|
3.8
|
29.5
|
1.0
|
O
|
H:HOH2159
|
3.8
|
19.2
|
1.0
|
N
|
H:ARG221A
|
3.9
|
21.1
|
1.0
|
H
|
H:ARG221A
|
3.9
|
25.4
|
1.0
|
O
|
H:HOH2171
|
4.0
|
25.4
|
1.0
|
HA
|
H:TYR225
|
4.0
|
19.4
|
1.0
|
C
|
H:ASP221
|
4.1
|
21.0
|
1.0
|
O
|
H:TYR184A
|
4.1
|
20.9
|
1.0
|
CA
|
H:LYS224
|
4.1
|
19.6
|
1.0
|
N
|
H:GLY223
|
4.2
|
24.6
|
1.0
|
N
|
H:ASP222
|
4.2
|
24.6
|
1.0
|
O
|
H:HOH2163
|
4.2
|
19.3
|
1.0
|
CA
|
H:ARG221A
|
4.3
|
22.6
|
1.0
|
CA
|
H:ASP222
|
4.3
|
25.3
|
1.0
|
CA
|
H:ASP221
|
4.4
|
21.1
|
1.0
|
N
|
H:TYR225
|
4.4
|
16.3
|
1.0
|
CB
|
H:LYS224
|
4.5
|
20.3
|
1.0
|
C
|
H:ASP222
|
4.5
|
24.6
|
1.0
|
O
|
H:ASP221
|
4.6
|
22.1
|
1.0
|
OD1
|
H:ASP221
|
4.6
|
20.9
|
1.0
|
CA
|
H:TYR225
|
4.7
|
16.1
|
1.0
|
HB2
|
H:ARG221A
|
4.8
|
27.9
|
1.0
|
C
|
H:GLY223
|
4.8
|
21.7
|
1.0
|
O
|
H:HOH2173
|
4.9
|
20.1
|
1.0
|
HB2
|
H:ASP189
|
4.9
|
19.1
|
1.0
|
HA
|
H:ARG221A
|
5.0
|
27.1
|
1.0
|
HA3
|
H:GLY184
|
5.0
|
17.8
|
1.0
|
H
|
H:ASP221
|
5.0
|
23.4
|
1.0
|
H
|
H:ASP222
|
5.0
|
29.5
|
1.0
|
|
Reference:
E.Ruehmann,
A.Heine,
G.Klebe.
Thrombin Inhibition To Be Published.
Page generated: Mon Oct 7 19:48:28 2024
|